A recent report published by Infinium Global Research on Helicobacter pylori (H. Pylori) non-invasive testing market provides an in-depth analysis of segments and sub-segments in the global as well as regional Helicobacter pylori (H. Pylori) non-invasive testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional Helicobacter pylori (H. Pylori) non-invasive testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of global Helicobacter pylori (H. Pylori) non-invasive testing market. According to the report, the global Helicobacter pylori (H. Pylori) non-invasive testing market is projected to grow at a CAGR of 4.2% over the forecast period of 2019-2025.

Market Insight

Helicobacter pylori is a gram-negative spiral bacterium found in the stomach. Helicobacter pylori comprise of a large diversity of strains, and hundreds of genomes that are entirely sequenced. Helicobacter pylori infection is diagnosed by invasive techniques such as endoscopy and biopsy. There are non-invasive techniques involved, they are the urea breath test, serology, urine detection, blood detection for Helicobacter pylori and its antigen in stool. Non-invasive test is further classified into active and passive infection testes. The urea breath test and stool antigen tests are active infection tests. Serology, urine detection, and blood detection are passive tests. The urea breath test has high accuracy as compared to serology and antigen stool test.

The rising prevalence of infections occurred through Helicobacter pylori and awareness against the same is driving the Helicobacter pylori non-invasive testing market. Helicobacter pylori are contagious, it is spread through the oral-oral route or fecal-oral route. Although the exact route of transmission is not known. Globally, 10% of children and 80% of adults are likely to have Helicobacter pylori infection. Rising Governments are taking initiatives for the eradication of Helicobacter pylori and thereby eliminating the risk of gastric cancer. Additionally, non-invasive techniques are available easily and they are cost effective. This leads to the growth of Helicobacter pylori non-invasive testing market. In Helicobacter pylori infection, the diagnosis rates are very low and the occurrence of infection is high.  In most of the cases, the bacteria do not show any symptom and it goes undiagnosed. The emergence of home diagnostic kits for Helicobacter pylori infection is providing the opportunity for the growth of Helicobacter pylori non-invasive testing market.

Amongst the Geographies, North America is holding the major market share in the Helicobacter pylori (H. Pylori) non-invasive testing market. The growing prevalence of Helicobacter pylori infection is boosting the growth of Helicobacter pylori non-invasive testing market. North America has the highest number of the aging population which increases the demand for diagnosis. Further, leading to the growth of the Helicobacter pylori non-invasive testing market in this region. Europe holds the second largest market share in the growth of the Helicobacter pylori non-invasive testing market due to an increase in companies investing in the non-invasive diagnosis of Helicobacter pylori infection. The Asia Pacific is estimated to be the fastest growing region for the Helicobacter pylori non-invasive testing market. This is by adopting new technologies in the market and rising population exposed to infections in this region. Additionally, the growing healthcare sector in this region is boosting the growth of Helicobacter pylori non-invasive testing market.

Segment Covered

The report on global Helicobacter pylori (h. pylori) non-invasive testing market covers segments such as test type, test method, and end-user. On the basis of test type, the sub-markets include serology test, and stool antigen test. On the basis of test method, the sub-markets include laboratory based tests, and point-of-care tests. On the basis of end-user, the sub-markets include hospitals, and clinics.

Companies Profiled:

The report provides profiles of the companies in the market such as Thermo Fisher Scientific, Meridian Bioscience, Inc., Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., DiaSorin S.p.A., Exalenz Bioscience Ltd., Certest Biotec S.L., CorisBioconcept SPRL, Sekisui Diagnostics, and Biomerica, Inc.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of Helicobacter pylori (H. Pylori) non-invasive testing market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.